Back

Pulmonary hypertension is associated with increased recurrence of atrial fibrillation post-pulmonary vein isolation: a multicenter study insights

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 5 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Eias Massalha

Sheba Medical Center, Ramat Gan (Israel)

7 More presentations in this session

Presentation thumbnail
Durability of pulmonary vein isolation after radiofrequency-balloon ablation
Doctor K. Plank (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Gastric hypomotility after adjunctive pulmonary vein and posterior wall isolation using cryoballoon in patients with atrial fibrillation: case control study
Doctor M. Esato (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
Acute safety and efficacy of ablation for atrial fibrillation in elderly patients by means of pulsed field ablation
Professor A. Dello Russo (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Multielectrode catheter-based pulsed field ablation of persistent and long-standing persistent atrial fibrillation
Doctor D. Della Rocca (Brussels, BE)
Abstract
Presentation thumbnail
An international multicentre experience with the third-generation laser balloon system: safety, efficiency, and efficacy
Doctor L. Bartoli (Luebeck, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 5 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Predictors of recurrence in atrial fibrillation patients undergoing pulmonary vein and posterior wall isolation
thumbnail
Congress Presentation
Long-term prognosis in patients undergoing atrial fibrillation ablation
thumbnail
Congress Presentation
Characterising recurrent atrial fibrillation after catheter ablation: patterns of pulmonary vein reconnection and predictors of complete pulmonary vein isolation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources